Braveheart Bio, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Braveheart Bio, Inc.'s yearly results, compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
—Data incomplete
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
—Data incomplete
Cash Cushion Ratio
—Data incomplete
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (6)
Braveheart Bio, Inc. made a loss over the last year. Braveheart Bio, Inc. owes $1.76 for every $1 it owns.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossBraveheart Bio, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
-20.17Braveheart Bio, Inc.'s book value is negative (it owes more than it owns), so P/B is not meaningful.
Market cap
$1.9 BThe total market value of all of Braveheart Bio, Inc.'s shares at today's price (share price × number of shares), larger than 74% of Healthcare companies in United States. PosiCap size class: Meso Cap.
Net worth (book value)
NegativeBraveheart Bio, Inc.'s net worth is negative ($96 M below zero, balance sheet 30 Jun 2026): it owes more than it owns, so book value per share and P/B are not meaningful.
Owes vs Owns
1.76×Braveheart Bio, Inc. owes $1.76 for every $1 it owns, so it owes more than it owns, higher than 95% of Healthcare companies in United States.
Dividend yield
NoneBraveheart Bio, Inc. does not currently pay a dividend.
Questions
How much does Braveheart Bio, Inc. owe compared with what it owns?
Braveheart Bio, Inc. owes $1.76 for every $1 it owns, so it owes more than it owns, higher than 95% of Healthcare companies in United States.
Does Braveheart Bio, Inc. pay a dividend?
No. Braveheart Bio, Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.